Skip to main content
Normal View

Covid-19 Pandemic

Dáil Éireann Debate, Wednesday - 3 February 2021

Wednesday, 3 February 2021

Questions (843)

Peadar Tóibín

Question:

843. Deputy Peadar Tóibín asked the Minister for Health if he will consider using ivermectin and colchicine in the treatment of Covid-19 [5803/21]

View answer

Written answers

At the request of NPHET, HIQA conducted a rapid evidence review to identify studies on the effectiveness of (i) pharmaceutical and (ii) non-pharmaceutical interventions, in the ambulatory setting, aimed at reducing progression to severe disease in individuals with confirmed or suspected COVID-19. Low certainty or very low certainty evidence was identified in relation to a small number of interventions. However, HIQA noted the low quality of the evidence available including the high risk of bias, small sample sizes and short durations of follow-up different trials and advised that results from these studies should not be used to inform decision-making with respect to effectiveness.

HIQA’s overall finding was that there is currently insufficient evidence of either effectiveness or safety to support the use of any pharmaceutical intervention in the community setting to reduce the risk of progression to severe disease in patients who have been diagnosed with COVID-19 unless as part of an ongoing monitored clinical trial. Furthermore, no evidence was identified for the effectiveness or safety of any non-pharmaceutical intervention in the community setting. The HIQA evidence review will be published shortly.

Top
Share